Exploring the Optimal Way to Measure & Monitor AAV Safety Signals in the CNS

Time: 9:30 am
day: Day Two


• Assessing the accuracy of imaging technology to inform on the AAV safety profile

• Identifying novel strategies to facilitate monitoring by using biomarkers

• Investigating CNS gene therapy deliver method to minimize safety events